IKBKB and chronic kidney disease: Since inhibition of the IKK2/NF-κB pathway unexpectedly worsened CKD-dependent vascular complications in in vitro and in vivo models, we next examined how activation of the NF-κB pathway affects CKD-dependent vascular complications by knocking out IκBα, which is a central inhibitor of the NF-κB pathway.